Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg

Clinical Therapeutics

Volumn 21, Issue 12, 1999, Pages 2058-2064

  Bekersky, Ihor ^a   Dressler, Dawna ^a   Mekki, Qais A ^a  

^a ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

Author keywords

Absorption; Linearity; Oral; Pharmacokinetics; Tacrolimus

Indexed keywords

TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG TOLERABILITY; GRAFT REJECTION; HUMAN; HUMAN EXPERIMENT; MALE; RANDOMIZED CONTROLLED TRIAL;

EID: 0033373092     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)87237-9     Document Type: Article

References (13)

1. 1. Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet. 1995; 29:404-430.
2. 2. Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: A new immunosuppressive agent. Am J Health-Syst Pharm. 1995; 52:1521-1535.
3. 3. Prograf® (tacrolimus capsules and injection) [package insert]. Deerfield, Ill: Fujisawa Healthcare, Inc; November 1998.
4. 4. Bekersky I, Dressler D, Boswell GW, et al. Bioequivalence of a new strength tacrolimus capsule under development. Transplant Proc. 1998;30:1457-1459.
5. 5. Jusko WJ, Thomson AW, Fung J, et al. Consensus document: Therapeutic drug monitoring of tacrolimus (FK-506). Ther Drug Monit. 1995;17:606-614.
6. 6. McMaster P, Mizra DF, Ismail T, et al. Therapeutic drug monitoring of tacrolimus in clinical transplantation. Ther Drug Monit. 1995;17:602-605.
7. 7. Floren LC, Bekersky I, Benet LZ, et al. Tacrolimus oral bioavailability doubles with coadministration of ketoconazole. Clin Pharmacol Ther. 1997;62:41-49.
8. 8. Herbert MF, Fisher RM, Marsh CL, et al. Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol. 1999;39:91-96.
9. 9. Metropolitan Life Insurance Company. 1983 Metropolitan Height and Weight Tables for Men and Women. Statistical Bulletin. New York: Metropolitan Life Insurance Co; 1983:1-8.
10. 10. Lee JW, Sukovaty RL, Farmen RH, et al. Tacrolimus (FK506): Validation of a sensitive enzyme-linked immunosorbent assay kit for and application to a clinical pharmacokinetic study. Ther Drug Monit. 1997;19:201-207.
11. 11. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker Inc.; 1982.
12. 12. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987;15:657-680.
13. 13. Data on file, report R95-0164-506-C4P-E. Deerfield, Ill: Fujisawa Healthcare, Inc; 1996.